|
Post by spiro on Dec 27, 2014 14:49:38 GMT -5
JPG, what percentage of PCP's do you think are currently prescribing insulin? I found this old survey, it seems they were able to find quite a few PCP's to participate. We know that Sanofi has diabetes product reps detailing PCP's in South Florida. Would over 50% be possible? www.ncbi.nlm.nih.gov/pmc/articles/PMC2408662/
|
|
|
Post by jpg on Dec 27, 2014 15:16:56 GMT -5
JPG, what percentage of PCP's do you think are currently prescribing insulin? I found this old survey, it seems they were able to find quite a few PCP's to participate. We know that Sanofi has diabetes product reps detailing PCP's in South Florida. Would over 50% be possible? www.ncbi.nlm.nih.gov/pmc/articles/PMC2408662/Hi Spiro, I wouldn't be able to answer more then say I would think the majority don't start prandial insulin and stick to basal for type 2s when they start insulin. I would also think there is significant 'shared insulin management" between PCP and endos. PCP that work with or have access to diabetic management structurnes (educational clinics, nurses that deal with frequent day to day patient questions etc) probably give a lot more basal and prandials then PCPs who have no access to such resources. Shared management is where I think Afrezza could change existing patterns of practice and, to a certain degree, worry endos. At the same time Afrezza could be a powerful tool to leverage the beneficial aspects of diabetic clinics. I would guess that insurers, MDs, patients and patient advocacy grouos at large will sooner rather then later catch on to this. JPG
|
|